Investor Ideas #Potcasts, #Cannabis News and Stocks on
the Move: (CSE: $AGRA.C) (CSE: $IAN.C) (CSE: $TRUL.C) and (NYSE: $ACB) (TSX: $ACB.TO)
Delta,
Kelowna, BC –April 4, 2019 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release today’s edition
of Investorideas.com potcastsCM - cannabis
news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/04041AGRA-IAN-TRUL-ACB.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another Investorideas.com “potcast”, looking at
cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today
we will be looking at announcements from AgraFlora Organics International
Inc. (CSE: AGRA) (OTC: PUFXF), iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF), Trulieve Cannabis Corp. (CSE: TRUL) (OTC:TCNNF) and Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB).
AgraFlora Organics
International Inc., a
growth oriented and diversified international cannabis company, and Relay
Medical Corp. (CSE: RELA) (OTCQB: RYMDF), a developer of MedTech innovation,
jointly referred to as the "Partners", announced the execution of a binding letter of
intent to bring Glow LifeTech Ltd., the cannabis technology joint venture,
public by way of reverse takeover. In December 2018 the Partners jointly
announced the formation of Glow to identify and develop technologies within the
global cannabis sector.
"Our
initial due diligence into the cannabis technology sector has indicated there
is significant demand for new technologies in all levels of the emerging
cannabis marketplace," said Derek Ivany, President and CEO, AgraFlora
Organics International. "AgraFlora's first venture in cannabis related
technology resulted in successful spin-off of the now publicly traded Cannvas
MedTech to the benefit of shareholders. Taking Glow LifeTech public through a
reverse takeover will provide the company with necessary capital to bring new
and proprietary technology to market, again to the benefit of all shareholders.
I look forward to working with the leadership team to execute on an aggressive
business strategy and finalizing the proposed transaction with Ateba."
iAnthus Capital
Holdings, Inc., which
owns, operates, and partners with best-in-class regulated cannabis operations
across the United States, announced a licensing agreement entered into between
its U.S. subsidiary and Blissiva, a women-owned, Maryland-based company
specializing in producing and distributing medical cannabis products
specifically formulated for women. As per the licensing agreement, iAnthus will
manufacture, market and sell a variety of Blissiva products in its markets,
with initial launch in Maryland scheduled for April 20, 2019. Additionally,
iAnthus has the exclusive right to launch Blissiva in its ten other existing
states and across the United States.
Blissiva
was founded by obstetrician gynecologist Dr. Leslie Apgar and serial
entrepreneur Gina Dubbé who have a mission to make medical cannabis more
accessible and desirable to women. Blissiva's first product, the Balance Pen,
was formulated specifically to help women combat stress and anxiety. The pen
first came to market in October 2018 and sold out in just six weeks of its
anticipated 12 week run. Blissiva is developing a line of additional products
designed for women's health, wellness and recreation.
"We
are extremely proud to partner with Blissiva in launching female-focused
cannabis products into the market. Women represent one of the largest and
fastest growing demographics of consumers in this industry, and there is
currently a lack of products specifically designed to address their health and
wellness needs. We believe that women should be able to 'have it all,' and I'm
excited to be working with Dr. Apgar, a groundbreaking expert in women's
health, to fill the gap in the industry," said Beth Stavola, Chief
Strategy Officer of iAnthus.
Leading
national cannabis company Trulieve
Cannabis Corp. announced today that it has signed an agreement with
California-based Blue River Extracts & Terpenes™ to bring their
award-winning terpene extracts and other trademark branded products to
Florida's growing patient base.
Blue
River™ is an industry-leading cannabis company that has focused on the
development of full spectrum solvent-less cannabis derived terpenes and began
utilizing terpenes with advanced mechanical extraction techniques to create an
array of award winning branded products including, Rosin, Dry Sift Sap, Vape
Cartridges, CBD Crystalline, Rosin Sauce, THCa, Flan™, and Jelly™, which earned
them over 50 cannabis awards to date. Blue River™ continued to shape the
landscape of the cannabis industry through their proprietary solvent-less
extraction technology and helped to popularize full-spectrum solvent-less
products with the use of cannabis derived terpenes.
"Blue
River™ has truly set the standard for innovation and excellence with their
terpene technology, creating products that are high-quality and one-of-a-kind.
Their dedication to quality, excellence, and standardization has changed the
landscape of the cannabis market and matches Trulieve's own dedication to the
same standards," said Trulieve CEO Kim Rivers. "Their products are an
effective, reliable option for patients seeking relief in innovative
ways."
Aurora Cannabis
Inc. today announced that the Company has appointed Carey
Squires as its Executive Vice President of Corporate Development and Strategy.
In this newly created role, reporting to the Executive Chairman, Mr. Squires in
collaboration with senior executives across the company will focus on global
growth and partnership strategies and investor development.
Mr.
Squires comes to Aurora with global investment banking experience, having most
recently served as Managing Director and Co-Head of Equity-Linked Capital
Markets for BMO Capital Markets. In this role, he successfully led the
financing for a number of issuers, including Aurora's recent convertible notes
offering. Mr. Squires received a B.Sc from the University of British Columbia
as well as an MBA from the Rotman School of Management at the University of
Toronto.
"With
deep experience in the U.S. and Canadian capital markets, Carey has been a
trusted advisor to Aurora on a variety of growth initiatives, including our
recently successful capital raise," said Michael Singer, Executive
Chairman of Aurora. "In this new position, Carey will be a core member of
Aurora's senior management team, executing on the development of key strategic
initiatives, including partnerships and M&A opportunities. We look forward
to working closely with Carey to leverage his extensive knowledge in the
execution of our investor development, international growth and partnership
strategies, sourcing potential accretive opportunities in the global cannabis
industry and negotiating favourable business transactions."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the
Investorideas.com website
and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an
Investor ideas member , plus get weekly updates with new pot stocks added and
get the daily potcast for Investor Ideas #Potcasts
#Cannabis News and Stocks on the Move.
Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner
and Podcast, Play by Play sports and stock
news column, Investor
Ideas #Potcasts #Cannabis News and Stocks
on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI Eye Podcast
and column covering developments in AI.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers.
Learn more about
Investor ideas podcast and news publication
services and costs https://www.investorideas.com/News-Upload/
Global investors
must adhere to regulations of each country.
Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does
not condone the use of cannabis except where permissible by law. Our site does
not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment